Noom Offers August Discounts and Free Trial Options for Weight-Loss Programs

Since its 2008 launch as a human-to-human weight-loss coaching service, Noom has expanded to incorporate psychology-based lessons, habit tracking and optional coaching across programs lasting four to twelve months. The platform now supports users of GLP-1 medications—including WeGovy, Ozempic and Zepbound—offering medical supervision, side-effect mitigation and lifestyle guidance, plus an AI companion for nutrition and exercise advice.

Promotional incentives currently feature a $20 reduction on the Microdose GLP-1 plan, which starts at $79 for a three-week subscription plus medication, and a free week-long trial that transitions to a $17.42 per month rate for a year-long commitment. GLP-1 prescriptions are available to eligible members at a baseline cost of $99, with specific drug prices beginning at $69. Additional tools such as a macros calculator help users tailor calorie and nutrient targets to personal goals.